Revolution Medicines, Inc.
MX ˙ BMV ˙ US76155X1000
SecurityMX:RVMD / Revolution Medicines, Inc.
InstitutionLogos Global Management LP
Latest Disclosed Ownership2,000,000 shares
Latest Disclosed Value $ 194,500,000
Logos Global Management LP ownership in RVMD / Revolution Medicines, Inc.

On May 15, 2026 - Logos Global Management LP filed a 13F-HR form disclosing ownership of 2,000,000 shares of Revolution Medicines, Inc. (MX:RVMD) valued at $194,500,000 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 2,000,000 shares of Revolution Medicines, Inc.. This represents a change in shares of 0.00% during the quarter.

Logos Global Management LP has a history of taking positions in derivatives of the underlying security (RVMD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:RVMD / Revolution Medicines, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F REVOLUTION MEDICINES COM 76155X100 2,000,000 0 0.00 194,500 22.10 9.7108
2026-02-17 2025-12-31 13F REVOLUTION MEDICINES COM 76155X100 2,000,000 250,000 14.29 159,300 94.92 9.6256
2025-11-14 2025-09-30 13F REVOLUTION MEDICINES COM 76155X100 1,750,000 50,000 2.94 81,725 30.67 7.3251
2025-08-14 2025-06-30 13F REVOLUTION MEDICINES COM 76155X100 1,700,000 100,000 6.25 62,543 10.55 6.9200
2025-05-15 2025-03-31 13F REVOLUTION MEDICINES COM 76155X100 1,600,000 150,000 10.34 56,576 -10.80 10.0572
2025-02-14 2024-12-31 13F REVOLUTION MEDICINES COM 76155X100 1,450,000 250,000 20.83 63,423 16.54 7.4210
2024-11-14 2024-09-30 13F REVOLUTION MEDICINES COM 76155X100 1,200,000 0 0.00 54,420 16.85 5.8715
2024-08-27 2024-06-30 13F/A-1 REVOLUTION MEDICINES COM 76155X100 1,200,000 1,200,000 46,572 3.7459
2024-08-14 2024-06-30 13F REVOLUTION MEDICINES COM 76155X100 1,200,000 1,200,000 46,572 3.7809
2024-05-15 2024-03-31 13F REVOLUTION MEDICINES COM 76155X100 0 -350,000 -100.00 0 -100.00
2024-02-14 2023-12-31 13F REVOLUTION MEDICINES COM 76155X100 350,000 100,000 40.00 10,038 45.06 0.9370
2023-11-14 2023-09-30 13F REVOLUTION MEDICINES COM 76155X100 250,000 250,000 6,920 0.9232
2020-08-14 2020-06-30 13F REVOLUTION MEDICINES COM 76155X100 0 -53,034 -100.00 0 -100.00
2020-05-15 2020-03-31 13F REVOLUTION MEDICINES COM 76155X100 53,034 53,034 1,162 0.4420
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F REVOLUTION MEDICINES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F REVOLUTION MEDICINES COM Call 1,000,000 0.00 79,650 70.56 n/a n/a n/a
2025-11-14 2025-09-30 13F REVOLUTION MEDICINES COM Call 1,000,000 46,700 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.